Clinical TrialID 5336
Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
NCT01747577
Overactive Bladder|Benign Prostate Hyperplasia|Transurethral Resection of Prostate|Photoselective Vaporization Prostatectomy
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5336
- Evidence Id
- 5336
- Core Evidence Id
- 5336
- Source Clinical Trial Id
- 5322
- Herb2 Clinical Trial Id
- HBCT005322
- Nct Id
- NCT01747577
- Title
- Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
- Status
- Completed
- Phase
- Phase 4
- Study Result
- No
- Study Condition
- Overactive Bladder|Benign Prostate Hyperplasia|Transurethral Resection of Prostate|Photoselective Vaporization Prostatectomy
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Solifenacin Succinate|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- Male
- Age
- Adult, Older_Adult
- Enrollment
- 68
- Outcome Measure
- Mean change from the baseline in the number of urgency episodes per 24 hrs in the voiding diary at Week 2, Baseline and at week 2
- Sponsor Collaborator
- Astellas Pharma Korea, Inc.
- Funded By
- INDUSTRY
- Location
- Soul, Korea, Republic of
- Other Id
- VC-OAB-12-01
- Start Date
- 2012-12-04
- Primary Completion Date
- 2013-10-24
- Completion Date
- 2013-10-24
- First Posted
- 2012-12-11
- Results First Posted
- Last Update Posted
- 2022-07-27
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01747577
- Title Cn
- Title En
- Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate)
- Bilingual Status
- semi_complete